跳至主要内容
临床试验/JPRN-UMIN000009222
JPRN-UMIN000009222已完成4 期

Drug therapy for the prevention of glucocorticoid induced osteoporosis in elderly patients: teriparatide or bisphosphonates? - Drug therapy for glucocorticoid induced osteoporosis in elderly patients

Department of Rheumatology & Clinical Immunology,Saitama Medical Center, Saitama Medical Universitity0 个研究点目标入组 40 人开始时间: 2012年11月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
65years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients who have serious renal disorder (egfr < 35 ml /min or cr > 1.5 mg/ml). 2)Patient who has a history of renal stone past 5 years. 3)Patients with primary or secondary hyperparathyroidism. 4)Patients with hyperthyroidism or hypothyroidism. 5)Patients who are considered to be contraindicated for bisphosphonates or teriparatide. 6)Patients who are treated with warfarin. 7)Patients who have experiences of receiving drugs having influence on bone remodeling within 6 months at inclusion of the study (pth,bisphosphonates, estrogen , vitamin d3, vitamin k2, serm (raloxifene, bazedoxifene), calcitonin, Ipriflavone, steroids) 8) Patients who are thought to be inappropriate for this study by physician.

研究者

发起方
Department of Rheumatology &amp; Clinical Immunology,Saitama Medical Center, Saitama Medical Universitity

相似试验

尚未招募
Unknown
Prophylactic use of glucocorticoids to reduce postoperative delirium in adult patients: A systematic review with meta-analysisAdult patients who underwent surgery
JPRN-UMIN000052979Teikyo University School of Medicine, Mizonokuchi Hospital1,000
进行中(未招募)
1 期
Prevention of Glucocorticoid induced impairment of bone metabolism – A Randomized, Placebo-Controlled, Single Centre Clinical TrialOral glucocorticoid (GC) therapy leads to a rapid and profound effects on bone metabolism.The gut microbiota is involved in regulating bone metabolism.Lactobacillus reuteri (LR) has been shown to have probiotic, health-promoting effects.The aim of this randomized, double-blind, placebo-controlled trial is to investigate if daily supplementation with LR, compared to placebo, can prevent the negative effects of oral GC on bone turnover and on blood glucose regulation in healthy young adults.
EUCTR2021-000275-36-SESahlgrenska University Hospital50
招募中
4 期
BLISS-POSTSystemic Lupus Erythematosus
JPRN-jRCTs071190045Tanaka Yoshiya100
尚未招募
不适用
Glucocorticoid-tapering aimed maintenance therapy in patients with systemic lupus erythematosussystemic lupus erythematosus
JPRN-UMIN000031259First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan100
已完成
不适用
A pilot study on prevention of glucocorticoid induced diabetes mellitus by linagliptiPatients scheduled administration of glucocorticoid
JPRN-UMIN000015588Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.17